Sean Bohen, AstraZeneca
In another major movement in AstraZeneca’s executive team, the company will have to find a new CMO after it was revealed that current incumbent, Sean Bohen, will move on from the company. Bohen will remain in the role until a replacement is found.
Bohen joined AZ’s leadership team after a 12-year stint as SVP of Genentech’s R&D department. Prior to this, he had worked Stanford University’s School of Medicine for nine years.
The movement at the top of AZ has also seen Bahija Jallal move to take the CEO reins at Immunocore earlier this month, and late last year saw its VP of cardiovascular, renal and metabolism leave to become Novo Nordisk’s head of biopharma.
